Nonclinical safety profiles of DS-1515, a novel oral PI3Kd inhibitor.

K. Yabe (Tokyo, Japan), M. Suzuki (Tokyo, Japan), K. Morimoto (Tokyo, Japan), K. Mori (Tokyo, Japan)

Source: International Congress 2018 – Basic pharmacology
Session: Basic pharmacology
Session type: Thematic Poster
Number: 1052
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Yabe (Tokyo, Japan), M. Suzuki (Tokyo, Japan), K. Morimoto (Tokyo, Japan), K. Mori (Tokyo, Japan). Nonclinical safety profiles of DS-1515, a novel oral PI3Kd inhibitor.. 1052

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: